View Financial HealthIndian Phosphate 配当と自社株買い配当金 基準チェック /06Indian Phosphate配当金を支払った記録がありません。主要情報n/a配当利回り0.1%バイバック利回り総株主利回り0.1%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Mar 10Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹61.55, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 15% over the past year.分析記事 • Feb 10Some Investors May Be Worried About Indian Phosphate's (NSE:IPHL) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹61.90, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 10% over the past year.分析記事 • Nov 23Indian Phosphate's (NSE:IPHL) Shareholders May Want To Dig Deeper Than Statutory ProfitIndian Phosphate Limited ( NSE:IPHL ) just released a solid earnings report, and the stock displayed some strength...New Risk • Nov 18New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 29% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹1.47b market cap, or US$16.6m).分析記事 • Nov 15There Is A Reason Indian Phosphate Limited's (NSE:IPHL) Price Is UndemandingIndian Phosphate Limited's ( NSE:IPHL ) price-to-earnings (or "P/E") ratio of 18.1x might make it look like a buy right...New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (₹1.57b market cap, or US$17.7m).お知らせ • Nov 14Indian Phosphate Limited to Report First Half, 2026 Results on Nov 14, 2025Indian Phosphate Limited announced that they will report first half, 2026 results on Nov 14, 2025Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹62.90, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 33% over the past year.お知らせ • Sep 08Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025, at 11:30 Indian Standard Time.Reported Earnings • Sep 08Full year 2025 earnings released: EPS: ₹3.92 (vs ₹7.21 in FY 2024)Full year 2025 results: EPS: ₹3.92 (down from ₹7.21 in FY 2024). Revenue: ₹8.86b (up 24% from FY 2024). Net income: ₹86.9m (down 34% from FY 2024). Profit margin: 1.0% (down from 1.8% in FY 2024). The decrease in margin was driven by higher expenses.New Risk • Sep 04New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended March 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2024 fiscal period end). Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.35b market cap, or US$15.4m).Board Change • Aug 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • May 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹52.25, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India.New Risk • Apr 01New major risk - Revenue and earnings growthRevenue has declined by 7.0% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.13b market cap, or US$13.2m).New Risk • Mar 22New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.21b market cap, or US$14.1m).Board Change • Mar 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.分析記事 • Mar 04Indian Phosphate Limited (NSE:IPHL) Stock's 29% Dive Might Signal An Opportunity But It Requires Some ScrutinyTo the annoyance of some shareholders, Indian Phosphate Limited ( NSE:IPHL ) shares are down a considerable 29% in the...Board Change • Nov 19High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Sep 19Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹115, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 36x in the Chemicals industry in India.Board Change • Sep 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.決済の安定と成長配当データの取得安定した配当: IPHLの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: IPHLの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Indian Phosphate 配当利回り対市場IPHL 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (IPHL)n/a市場下位25% (IN)0.3%市場トップ25% (IN)1.5%業界平均 (Chemicals)0.7%アナリスト予想 (IPHL) (最長3年)n/a注目すべき配当: IPHLは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: IPHLは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: IPHLの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: IPHLが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YIN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 13:29終値2026/05/21 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Indian Phosphate Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹61.55, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 15% over the past year.
分析記事 • Feb 10Some Investors May Be Worried About Indian Phosphate's (NSE:IPHL) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹61.90, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 10% over the past year.
分析記事 • Nov 23Indian Phosphate's (NSE:IPHL) Shareholders May Want To Dig Deeper Than Statutory ProfitIndian Phosphate Limited ( NSE:IPHL ) just released a solid earnings report, and the stock displayed some strength...
New Risk • Nov 18New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 29% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹1.47b market cap, or US$16.6m).
分析記事 • Nov 15There Is A Reason Indian Phosphate Limited's (NSE:IPHL) Price Is UndemandingIndian Phosphate Limited's ( NSE:IPHL ) price-to-earnings (or "P/E") ratio of 18.1x might make it look like a buy right...
New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (₹1.57b market cap, or US$17.7m).
お知らせ • Nov 14Indian Phosphate Limited to Report First Half, 2026 Results on Nov 14, 2025Indian Phosphate Limited announced that they will report first half, 2026 results on Nov 14, 2025
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹62.90, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 33% over the past year.
お知らせ • Sep 08Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025, at 11:30 Indian Standard Time.
Reported Earnings • Sep 08Full year 2025 earnings released: EPS: ₹3.92 (vs ₹7.21 in FY 2024)Full year 2025 results: EPS: ₹3.92 (down from ₹7.21 in FY 2024). Revenue: ₹8.86b (up 24% from FY 2024). Net income: ₹86.9m (down 34% from FY 2024). Profit margin: 1.0% (down from 1.8% in FY 2024). The decrease in margin was driven by higher expenses.
New Risk • Sep 04New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended March 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2024 fiscal period end). Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.35b market cap, or US$15.4m).
Board Change • Aug 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • May 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹52.25, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India.
New Risk • Apr 01New major risk - Revenue and earnings growthRevenue has declined by 7.0% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.13b market cap, or US$13.2m).
New Risk • Mar 22New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.21b market cap, or US$14.1m).
Board Change • Mar 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Mar 04Indian Phosphate Limited (NSE:IPHL) Stock's 29% Dive Might Signal An Opportunity But It Requires Some ScrutinyTo the annoyance of some shareholders, Indian Phosphate Limited ( NSE:IPHL ) shares are down a considerable 29% in the...
Board Change • Nov 19High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Sep 19Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹115, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 36x in the Chemicals industry in India.
Board Change • Sep 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.